These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3927865)

  • 1. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants.
    Glueck HI; Kant KS; Weiss MA; Pollak VE; Miller MA; Coots M
    Arch Intern Med; 1985 Aug; 145(8):1389-95. PubMed ID: 3927865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clotting defect in SLE.
    Byron MA
    Clin Rheum Dis; 1982 Apr; 8(1):137-51. PubMed ID: 6811189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors.
    Sallai KK; Nagy E; Bodó I; Mohl A; Gergely P
    Scand J Rheumatol; 2007; 36(3):198-205. PubMed ID: 17657674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between antiphospholipid antibodies and arterial or venous thrombosis/thrombocytopenia].
    Nojima J; Suehisa E; Kuratsune H; Amino N
    Rinsho Byori; 1998 Dec; 46(12):1181-7. PubMed ID: 9916502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Circulating anticoagulants with antiprothrombinase activity in systemic lupus erythematosus (author's transl)].
    Gazengel C; Dougados M; Kremp O; Tron F; Noël LH; Jungers P
    Nouv Presse Med; 1980 Sep; 9(33):2325-8. PubMed ID: 7433022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
    Ames PR; Pyke S; Iannaccone L; Brancaccio V
    Thromb Haemost; 1995 May; 73(5):768-73. PubMed ID: 7482401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of lupus anticoagulant, autoimmune hemolysis, thrombocytopenia and disorders of platelet function in unselected patients with SLE].
    Söhngen D; Specker C; Wehmeier A; Kiefel V; Rathmer L; Söhngen R; Schneider W
    Beitr Infusionsther; 1992; 30():469-73. PubMed ID: 1284763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
    Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
    Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
    Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
    Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulation of coagulo-fibrinolytic activity and lupus anticoagulants in systemic lupus erythematosus].
    Fusegawa H; Ichikawa Y; Tanaka Y; Shiba T; Kawada T; Shimizu H; Moriuchi J; Arimori S; Ando Y
    Ryumachi; 1990 Apr; 30(2):90-8. PubMed ID: 2122531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
    Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
    Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole blood viscosity and arterial thrombotic events in patients with systemic lupus erythematosus.
    Booth S; Chohan S; Curran JC; Karrison T; Schmitz A; Utset TO
    Arthritis Rheum; 2007 Jun; 57(5):845-50. PubMed ID: 17530685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.
    Afeltra A; Vadacca M; Conti L; Galluzzo S; Mitterhofer AP; Ferri GM; Del Porto F; Caccavo D; Gandolfo GM; Amoroso A
    Arthritis Rheum; 2005 Jun; 53(3):452-9. PubMed ID: 15934123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
    Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
    Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An atypical manifestation of acquired von Willebrand syndrome (AVWS) associated with systemic lupus erythematosus (SLE).
    Kasatkar P; Ghosh K; Shetty S
    Ann Hematol; 2014 Jan; 93(1):173-5. PubMed ID: 23625134
    [No Abstract]   [Full Text] [Related]  

  • 18. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin, protein S and protein C and antiphospholipid antibodies in systemic lupus erythematosus.
    Costallat LT; Ribeiro CC; Annichino-Bizzacchi JM
    Sangre (Barc); 1998 Oct; 43(5):345-8. PubMed ID: 9868323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis.
    Kaplanski G; Cacoub P; Farnarier C; Marin V; Grégoire R; Gatel A; Durand JM; Harlé JR; Bongrand P; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):55-64. PubMed ID: 10643700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.